<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Act 1934
Date of Report (Date of earliest event reported) March 17, 1995
-------------------------------
Respironics, Inc.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
<TABLE>
<CAPTION>
<S> <C> <C>
Delaware 000-16723 25-1304989
- --------------------------------------------------------------------------------
State or other jurisdiction Commission IRS Employer
of incorporation File Number identification
Employees
</TABLE>
1001 Murry Ridge Drive, Murrysville, PA 15668
- --------------------------------------------------------------------------------
(Address of principal executive officers) (Zip)
Registrant's telephone number, including area code (412) 733-0200
-----------------------------
- --------------------------------------------------------------------------------
(Former name and former address, if changed since last report)
<PAGE>
<TABLE>
<C> <S>
Item 1. Changes in Control of Registrant
None
Item 2. Acquisition or Disposition of Assets.
On March 17, 1995, Respironics announced that it had agreed to
acquire Vitalog Monitoring, Inc., a privately held, California-
based designer, manufacturer and marketer of sleep monitoring
and diagnostic equipment (see press release attached).
Item 3. Bankruptcy or Receivership.
None
Item 4. Changes in Registrant's Certifying Accountant.
None
Item 5. Other Events.
None
Item 6. Resignation of Registrant's Directors.
None
Item 7. Financial Statements and Exhibits.
Exhibit
Number
99.1 Respironics Inc. Press Release, dated March 17, 1995, regarding
Acquisition of Vitalogic Monitoring, Inc.
</TABLE>
<PAGE>
Pursuant to the requirements of the Securities and Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Respironics, Inc.
------------------------------
(Registrant)
3.29.95 /s/ Dorita A. Pishko
- --------- ------------------------------
(Date) (Signature)
Dorita A. Pishko
Corporate Secretary
<PAGE>
[LOGO OF RESPIRONICS INC.]
PRESS RELEASE
Contact: Dorita A. Pishko
Respironics, Inc.
(412) 733-0209
RESPIRONICS TO ACQUIRE VITALOG--A DESIGNER, MANUFACTURER,
---------------------------------------------------------
AND MARKETER OF SLEEP MONITORING EQUIPMENT
------------------------------------------
MURRYSVILLE, PA, MARCH 17, 1995 - RESPIRONICS, INC. (NASDAQ/NMS)
Symbol: RESP) announced today that it has agreed to acquire Vitalog Monitoring,
Inc., a privately held, California-based designer, manufacturer, and marketer of
sleep monitoring and diagnostic equipment. The transaction is expected to be
concluded in April. Terms were not disclosed.
The acquisition expands Respironics' participation in a growing
worldwide effort to diagnose and treat sleep disorders, noted Dennis S. Meteny,
the company's president and chief executive officer. "Vitalog's products are an
appropriate complement to our therapeutic systems for the treatment of
obstructive sleep apnea, and they represent a natural extension of our largest
single business segment," he said.
Under terms of the agreement, Dr. Laughton Miles - one of Vitalog's
principal owners - will join Respironics in a senior new product development
capacity. "Dr. Miles' innovations created significant technological advantages
for Vitalog in the sleep monitoring field," Mr. Meteny stated. "He will
continue to apply his expertise in that area while contributing to the
development of the therapeutic devices that have traditionally formed the core
of Respironics' business base," the chief executive added.
- MORE -
--------------------------------------------------
1001 Murry Ridge Drive, Murrysville, PA 15668-8550
412/733-0200 Fax: 412/733-0299
<PAGE>
Ms. Zeala Dunlop Miles--the other principal owner and current
president of Vitalog--will also join Respironics in an international sales and
marketing capacity. "Ms. Miles has developed strong international dealer
relationships over the years, and we plan to utilize her skills in this area as
we integrate our two businesses," Mr. Meteny further stated.
Robert D. Crouch, vice president of sales and marketing stated, "We
look forward to the opportunity to offer additional devices and technology to
the sleep apnea market place and are confident that Vitalog's products coupled
with the development efforts of Dr. Miles will further enhance our ability to
serve our customers." Headquartered in Redwood City, Vitalog's annual sales
total approximately $1 million.
Respironics, Inc. designs, develops, manufactures and sells
respiratory medical products for use in the home, hospitals, and in emergency
care situations. The company recently was awarded the American Association for
Respiratory Care's annual Zenith Award for quality of products and service for
the third time in the past four years. Respironics was one of five firms
selected from the 358 eligible for the award in 1994.
# # #
